In addition to the significant difference in microstructure and mechanics of posterior and anterior stroma, it is well developed that the collagen crosslinking procedure creates primarily crosslinks in the anterior corneal stroma.
30,32–35 The depth-dependent stiffening of the collagen crosslinking has been shown by different methods such as mechanical tests of anterior and posterior flaps dissected from crosslinked corneas and Brillouin microscopy of treated samples.
30,34 Other methods have also showed that collagen crosslinking primarily affects the anterior part of stroma. For example, keratocyte apoptosis was observed to be limited to the anterior stroma and a demarcation line was observed in the anterior corneal stroma of collagen crosslinking corneas.
32,33 Finally, the spatial distribution of the corneal stiffening due to the collagen crosslinking has been captured by a numerical model.
35 There are also significant differences between swelling behavior of anterior and posterior cornea. Thus, the changes in hydration at the macro scale (or changes in collagen interfibrillar spacing at the micro scale) caused by application of hypoosmolar or isoosomolar solution occur mainly in the posterior stroma, where the collagen lamellae are parallel to each other.
36,37 For instance, Müller et al.
37 observed that top 100 μm of the anterior stroma showed strong resistant to swelling when immersed in water. Putting all these together, we can conclude that when samples are artificially swollen by using a hypoosmolar riboflavin solution, the microstructure of the anterior part of the cornea, where crosslinks are induced, does not alter significantly. Thus, these samples should behave similarly to those crosslinked using the common crosslinking solution. (Note that both groups are required to be tested at the same thickness (hydration) to nullify the hydration effects on measured properties.
16,17) The results shown in
Figure 4 support this discussion. The slight difference in the curves corresponding to the mechanical response of samples crosslinked at different thickness (590, 750, 1100, and 1300 μm) and tested at 750 μm could be either because the hydration of anterior layers varied slightly as thickness (hydration) of the whole tissue increased or because of the intrinsic differences between the mechanical properties of specimens. Although this study did not include any data on behavior of keratoconic corneas, its findings can be used to speculate why crosslinking with hypoosmolar riboflavin solution is successful for thin corneas but not for extremely thin corneas. First, it needs to be mentioned that the disease in extremely thin corneas has often progressed thus far that their inflammatory profile is expected to be too strong to be mediated by biomechanical stiffening. Hafezi reported that corneal collagen crosslinking using hypoosmolar riboflavin solution failed to arrest the disease progression in a patient with very thin cornea.
13 The preoperative stromal thickness of this patient was 268 μm; thus, the treatment was not effective possibly because the thickness of the anterior portion was not sufficient. In other words, the collagen crosslinking mostly affects the anterior corneal stroma and the posterior stroma does not stiffen significantly by crosslinking.
34,38 Future studies (possibly on keratoconus corneas) are required to determine the required minimum thickness of anterior corneal stroma for a successful crosslinking treatment and to explain better implications of the present study for effects of collagen crosslinking on keratoconic corneas. Future studies are also required to determine whether a distinct anterior stromal layer is even present in extremely thin corneas and whether its presence makes a difference in effectiveness of collagen crosslinking treatment.